The Department of Commerce has determined that Pioneer Natural Resources and Enterprise Products Partners could start exporting condensate, an ultralight type of crude
The $3.5 billion merger highlights how little has changed in the stubbornly old-fashioned way we buy and sell houses
The Supreme Court has seemed hesitant to hear a gun-rights case for the past four years, but that spell looks likely to end.
OKCupid does all sorts of interesting research on its users—just like Facebook
“Procrastination and inattention” cause homeowners to leave money on the table, says a prize-winning academic research paper
Remember when Wolf Blitzer talked to Jessica Yellin’s hologram in 2008? HologramUSA envisions so much more
A lot more workers, especially in high-earning professions, are overworking than they used to -- and most are men.
Thanks to a quirk in Federal law, most students of the company's shuttered for-profit schools can't do anything about their student debt.
AirSign, the skywriting company behind a recent Comic-Con campaign, sees an opportunity in airborne social media
Founders: Dr. Daniel J. Abrams; Tom Anchordoquy, PhD; and Karen Stevens, PhD
VC Investment over the last four quarters: $21.5 million
Founded in 2005, this seven-person biopharmaceutical company develops drugs for the treatment of severe central nervous system diseases. In addition to VC funding, Sierra received about $230,000 in grants from the State of Colorado, the University of Colorado, and the Coleman Institute. As for the recession, its founders say the company will be keeping close tabs on the funding and partnership environment over the next two to three years, despite already being funded for drug development work for the next three years.
Key to startup success: "Be persistent in the development of your data and business model to enable you to create a financial model that has a high likelihood of helping patients and therefore is fundable by the investor community."